DOSSIER · UPDATED 18 NOV 2025

Umoja Biopharma

Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer. The company's treatment approach retools a patient’s immune system in vivo to direct potent anti-cancer immune cells to a…

umoja-biopharma.com ↗Claim this profile

Founded: 2019
Headcount: 112
Open roles: 17
Last raised: Series C · $100M

SECTION I · THE BRIEF

Inside Umoja Biopharma

Brief #69270Updated 18 NOV 2025SEATTLEMEDICAL ORGANIZATIONSSERIES C

Employbl Dossier

Umoja Biopharma

Founded: 2019
Headcount: 112
Open roles: 17
Last raised: Series C · $100M

Section II — RestrictedMembers only

Engineering interview process at Umoja Biopharma
Tech stack & infrastructure choices
Culture & day-to-day work style
Why join now vs. 6 months from now
Hiring focus & open headcount by team
Comp philosophy and band context

Open Umoja Biopharma brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Michael Jensen

Andy Scharenberg

Philip Low

Ryan Crisman

OPEN ROLES

Hiring at Umoja Biopharma

Current Job Listings

Listing 0 of 17 job openings

FUNDING

Capital raised

Total Amount Raised: $363,000,000

Umoja Biopharma's Investors

Softbank Vision Fund

Umoja Biopharma Funding Rounds

Series C
$100,000,000
Jan 14, 2025
Series C
$100,000,000
Jan 13, 2025
Series C Investors
DCVC Bio
Double Point Ventures
Cormorant Asset Management
MPM Capital
Qiming Venture Partners USA
CaaS Capital Management
RTW Investments
Myeloma Investment Fund
Alexandria Venture Investments
K2 HealthVentures
ARK Investment Management
SoftBank Vision Fund
Emerson Collective
Series B
$210,000,000
Jun 15, 2021
Series B
$210,000,000
Jun 14, 2021
Series B Investors
Cormorant Asset Management
SoftBank Vision Fund
CaaS Capital Management
Temasek
Presight Capital
RTW Investments
SVB Leerink
Series A
$53,000,000
Nov 18, 2020
Series A
$53,000,000
Nov 17, 2020
Series A Investors
MPM Capital
Qiming Venture Partners USA
DCVC Bio